In the first five years since its formation, ATRI has established itself as a global Alzheimer’s disease research institute conducting high quality research attracting funding from the public and private sectors. The initial team of 40 has grown to include seven faculty with academic appointments at the USC Department of Neurology and approximately 170 research and administrative staff.
Major collaborations with the National Institutes of Health (NIH), Alzheimer’s Association and several industry partners make ATRI one of the largest and most successful independent programs, both at USC and elsewhere. ATRI continues to be an evolving enterprise; in terms of clinical trials, grants and publications.